In some researches, CRISPR-dCas9-VPR was utilized to target the ERIC locus, revealing that its overexpression in T24 and 5637 BC cells significantly suppressed proliferation and invasiveness while promoting apoptosis. The gene discussed is ERICD; the disease is breast cancer.